Panaxadiol promotes angiogenesis against chronic cerebral hypoperfusion injury through the VEGF-A/p38 MAPK/Src signaling pathway
PD ameliorates BCAS-induced cognitive deficits by promoting angiogenesis through the VEGF-A/p38 MAPK/Src signaling pathway, highlighting its potential as a therapeutic agent for CCH and VCI.
Authors
- Changhong Ren (ORCID: https://orcid.org/0000-0002-4230-784X)
- Meng Geng
- Sijie Li (ORCID: https://orcid.org/0000-0002-8329-1186)
- Xunming Ji (ORCID: https://orcid.org/0000-0003-0293-2744)
- Fang Tong (ORCID: https://orcid.org/0000-0002-7203-9583)
- Linhui Qin (ORCID: https://orcid.org/0000-0002-6070-4881)
- Yumeng Wang (ORCID: https://orcid.org/0000-0002-2282-0814)
- Wenbo Zhao (ORCID: https://orcid.org/0000-0002-9114-5453)
- Jun Xu (ORCID: https://orcid.org/0000-0003-1444-1336)
Institutions
- Capital Medical University (CN)
- Zhengzhou University (CN)
- Chinese Institute for Brain Research (CN)
- Inner Mongolia Medical University (CN)
Publication Details
- Journal
- Journal of Ginseng Research
- Published
- 2025-10-07
- DOI
- https://doi.org/10.1016/j.jgr.2025.10.001
- Primary Topic
- Neurological Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00